COCP
COCP
NASDAQ · Pharmaceuticals

Cocrystal Pharma Inc

$1.03
-0.06 (-5.50%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,610.7% upside
Low Target $19.61
Average Target $27.92
High Target $38.36
Current Price $1.03
Current
$1.03
Target
$27.92
$19.61 $27.92 avg $38.36
Scenario Analysis
Bear Case
$19.61
1,803.9%
Low target
Base Case
$27.92
+2,610.7%
Avg target
Bull Case
$38.36
+3,624.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.67
-61.4% from high
52-Week Low
$0.86
+19.9% from low
Target vs 52W High
$27.92
+945.7% vs high
Next Earnings Report
Apr 6, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.18
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%